A novel bardoxolone methyl derivative, dh404, has been shown to attenuate endothelial dysfunction, reduce Nox1 expression, decrease oxidative stress, and inhibit inflammation in diabetic mice, suggesting that upregulation of Nrf2 may have therapeutic potential to limit diabetes-associated vascular damage.114. Here, NFE2L2 is linked to diabetes mellitus.